FHI vs FSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

FHI

62.6
AI Score
VS
FHI Wins

FSK

39.6
AI Score

Investment Advisor Scores

FHI

63score
Recommendation
STRONG BUY

FSK

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI FSK Winner
Forward P/E 9.9206 7.9239 FSK
PEG Ratio 1.3978 3.2724 FHI
Revenue Growth 18.3% -27.1% FHI
Earnings Growth 19.3% 33.8% FSK
Tradestie Score 62.6/100 39.6/100 FHI
Profit Margin 21.3% -28.5% FHI
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY FHI

Relative Price Performance (Last 90 Days)

FHI 1M: -0.8% · 3M: -3.8% FSK 1M: -12.0% · 3M: -4.9%

Current Technical Phase

FHI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $55.93

FSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.33

Fundamentals Snapshot

Metric FHI FSK
Market Cap — —
Forward P/E 9.4 6.9
Trailing P/E 10.2 —
Revenue (TTM) — —
Revenue Growth 0.2% -0.3%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.7%
EPS 5.51 -1.35
Dividend Yield 0.03% 0.20%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.